Fully consultative, point-by-point guidance to
smarter antibody discovery

Therapeutic Antibody Discovery

Toward the wellness of people.

LEARN MORE

Critical Reagent Antibody Discovery

Toward the soundness of medicine.

LEARN MORE

Our Flexible Cellestive Pathways

PathwayA-icon

Hybridoma Library

Our B-cell fusion and hybridoma generation platform immortalizes the immune response by combining optimized fusion techniques and proprietary growth medium formulations to promote diversity and stability of the hybridoma population. Single- cell sorting of true clones by Flow Cytometry both improves the fidelity of screening and expedites the discovery process, since as no further sub-cloning is required.
Cellestive_web_path_A_1
Cellestive_web_path_A_2
Hybridoma Libraries we produce on your behalf are designed to deliver enduring value: they’re cryopreserved to maximize efficiency and flexibility while also minimizing your overhead costs of future research. Our high- yield hybridoma culture system allows for multiplexed high-throughput screening, including binding and even functional assays to interrogate thousands of clones and identify desired hits in a single round of screening.
PathwayB-icon

Primary B-Cell

Direct interrogation and sequencing of single B-cells is a critical component of our antibody discovery platform, especially as the industry focus has continued to shift its focus to more difficult therapeutic targets. 
Cellestive_web_path_B_1
Cellestive_web_path_B_2
Robust single-cell isolation, screening and sorting capabilities are combined with optimized V(D)J amplification for multiple species and next- generation sequencing technology to yield antigen-specific B-cell sequences that maintain cognate VH and VL pairing.

In addition, De Novo gene synthesis and recombinant expression of antibody sequences in mammalian cells allows for rapid validation and lead selection.
PathwayC-icon

Guided NGS

A truly comprehensive antibody discovery platform requires the integration of multiple technologies and workflows to deeply interrogate the immune response while also delivering multiparameter functional screening data. 
Demo-Illustration1
Cellestive_web_path_C_2
Our Guided NGS approach combines single B-cell sequence informatics with the high-throughput functional screening capabilities of the Hybridoma Library platform to provide a road map for successful navigation of the immune repertoire. The end result is a more efficient and cost-effective platform for deep mining of the antigen-specific B-cell population.
Challenges_Responses-icon

Bright, Distinct Responses to Your Antibody Discovery Challenges

Calc-icon

Your Challenge:
Fair Pricing Models

I want to explore multiple discovery methods or technologies but it would stress the budget and the associated downstreams make it unattractive for investors.

Cycle-icon

Our Response:
We’re Calibrated

Good science and cost-effective approaches are not mutually exclusive. We can provide multiple pathways to reduce time-to-market and optimize resources.

Paper-icon2

Your Challenge:
Vendor Tech Biases

I’m finding that too many research organizations are tied to specific platforms, offerings or approaches, whether or not those are the best tools for the job.

Stars-shape2-icon2

Our Response:
We’re Flexible

We aren’t beholden to one distinct method, technique or technology. We have the scientific agility, vision, audacity to follow where the science leads us – right to the surest approach(es) for your project.

Search-icon2

Your Challenge:
Insufficient Support

I know the discovery goal my organization wants to reach, but need guidance from a team with the breadth of vision and specialized expertise that we lack in order to reach those goals.

Stars-shape-icon2

Our Response:
We’re Thorough

Our clients will ultimately always choose which pathways to travel, but they’ll make those decisions based on our thorough presentation of all the options, methods, and costs.

Let’s Illuminate a Better Way Together

Cellestive gives our most discerning clients all the options they need to optimize their antibody discovery. So how will your stars align? Let’s initiate the Cellestive process and find out together.

Contact Us